RICC A/S: Financial statements 2014
CVR: 20690003
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
RICC A/S (CVR 20690003) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 138,204,000 and a net result of DKK -5,462,000. Equity in the 2014 report amounted to DKK -67,982,000.
- Gross Profit
- DKK 138,204,000
- Profit/Loss
- DKK -5,462,000
- Equity
- DKK -67,982,000
- Total Assets
- DKK 75,534,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of December 17, 2014, KPMG P/S has been appointed auditor of RICC A/S.
As of December 17, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of RICC A/S.
On September 24, 2014, the company changed its name from SANTARIS PHARMA A/S to ROCHE INNOVATION CENTER COPENHAGEN A/S.
As of September 2, 2014, Henrik Ørum has joined the board of directors of RICC A/S.
As of September 2, 2014, Ronald Jeyung Park has joined the board of directors of RICC A/S.
As of September 2, 2014, John Christian Reed has joined the board of directors of RICC A/S.
As of September 2, 2014, Beat Christoph Krähenmann has joined the board of directors of RICC A/S.
As of September 2, 2014, Claus Tycho Bræstrup has left the board of directors of RICC A/S.
As of September 2, 2014, Claus Asbjørn Andersson has left the board of directors of RICC A/S.
As of September 2, 2014, Søren Knud Carlsen has left the board of directors of RICC A/S.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.